Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Bicarbonate for Prevention of Contrast Nephropathy
NCT00312117Phase 3Completed
- Sponsor
- Kaiser Permanente
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sodium bicarbonate in contrast-induced nephropathy (CIN), sponsored by Kaiser Permanente. Started Jan 2006; status: completed.
02
Drugs
sodium bicarbonate
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on NCT00312117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00312117.